DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise
Key Takeaways DXCM Q2 sales rose 15.2% to 4.6-$4.625B, citing new coverage wins and strong CGM demand momentum.DexCom, Inc. (DXCM) reported second-quarter 2025 adjusted earnings per share (EPS) of 48 cents, which beat the Zacks Consensus Estimate of 45 cents by 6.7%. The company reporte ...